Search filters

List of works by Mark S Freedman

A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study

scientific article published on 12 February 2020

Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS

scientific article published on 26 September 2019

Defining the clinical course of multiple sclerosis: the 2013 revisions

scientific article

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

scientific article published on 21 December 2017

Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials

scientific article published in March 2018

Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast Agents

scientific article published on 23 August 2018

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci

scientific article

Molecular mechanism underlying the impact of vitamin D on disease activity of MS.

scientific article

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

scientific article

Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis: Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study

scientific article published on 05 July 2016

Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study

scientific article published on 11 June 2013

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

scientific article published on 26 May 2017

Vitamin D as an early predictor of multiple sclerosis activity and progression

scientific article published on March 2014

Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT

scientific article published on 16 April 2020